We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO EVENTS

EVENTS

WEBINARS

NOV 10 2021

Is Repurposing Off-Patent Drugs a Viable Development Strategy? - Outsourcing in Clinical Trials

Nov 10 2021

9:30 AM - 10:30 AM

Edward John Allera, shareholder and co-chair of the firm's FDA group and Matthew Fedowitz, shareholder in the firm’s IP section and Life Sciences industry group, are serving as panelists during the Outsourcing in Clinical Trials conference session, “Is Repurposing Off-Patent Drugs a Viable Development Strategy?”